FRAX® assessment of osteoporotic fracture probability in Switzerland

Osteoporosis International

Volumn 21, Issue 3, 2010, Pages 381-389

  Lippuner, K ^a,d   Johansson, H ^b   Kanis, J A ^b   Rizzoli, R ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

10 year fracture probability; Clinical risk factors; FRAX ; Hip fracture; Osteoporotic fracture

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FAMILY HISTORY; FEMALE; FRACTURE RISK ASSESSMENT; FRAGILITY FRACTURE; GROUPS BY AGE; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SWITZERLAND; AGE; EPIDEMIOLOGY; FEMUR NECK; GENETIC PREDISPOSITION; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY;

ABSORPTIOMETRY, PHOTON; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BONE DENSITY; EPIDEMIOLOGIC METHODS; FEMALE; FEMUR NECK; GENETIC PREDISPOSITION TO DISEASE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; SWITZERLAND;

EID: 76549121093     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0975-1     Document Type: Article

References (44)

1. JA Kanis N Burlet C Cooper, et al. 2008 European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 19 399 428 10.1007/s00198-008-0560-z 1:STN:280:DC%2BD1c3itFekuw%3D%3D 18266020
2. K Lippuner M Golder R Greiner 2005 Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland Osteoporos Int 16 Suppl 2 S8 S17 10.1007/s00198-004-1696-0 15378232 (Pubitemid 46232116)
3. Mathers CD, Murray CJL, Lopez AD et al (2001) World Health Organization Global Programme on Evidence for Health Policy Discussion Paper No. 38. http://www.who.int/healthinfo/paper38.pdf. Accessed on May 13, 2006
4. JM Robine F Paccaud 2005 Nonagenarians and centenarians in Switzerland, 1860-2001: a demographic analysis J Epidemiol Community Health 59 31 37 10.1136/jech.2003.018663 15598723 (Pubitemid 40037083)
5. Bundesamt für Statistik. Szenarien zur Bevölkerungsentwicklung der Schweiz 2005-2050. http://www.bfs.admin.ch/bfs/portal/de/index/news/ publikationen.Document.83713.pdf. Accessed on May 14, 2008
6. M Schwenkglenks K Lippuner HJ Hauselmann, et al. 2005 A model of osteoporosis impact in Switzerland 2000-2020 Osteoporos Int 16 659 671 10.1007/s00198-004-1743-x 15517190 (Pubitemid 40897464)
7. (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646-650
8. JA Kanis LJ Melton 3rd C Christiansen, et al. 1994 The diagnosis of osteoporosis J Bone Miner Res 9 1137 1141 10.1002/jbmr.5650090802 1:STN:280:DyaK2M%2FmslSisA%3D%3D 7976495
9. JA Kanis EV McCloskey H Johansson, et al. 2008 A reference standard for the description of osteoporosis Bone 42 467 475 10.1016/j.bone.2007.11.001 1:CAS:528:DC%2BD1cXitVOmtbk%3D 18180210
10. JA Kanis O Johnell A Oden, et al. 2000 Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis Bone 27 585 590 10.1016/S8756-3282(00)00381-1 1:STN:280:DC%2BD3M%2FktlOqsg%3D%3D 11062343 (Pubitemid 30808794)
11. ES Siris PD Miller E Barrett-Connor, et al. 2001 Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment Jama 286 2815 2822 10.1001/jama.286.22.2815 1:STN:280:DC%2BD3MjgtVGmug%3D%3D 11735756
12. N Suhm O Lamy K Lippuner 2008 Management of fragility fractures in Switzerland: results of a nationwide survey Swiss Med Wkly 138 674 683 18855150
13. JA Kanis A Oden O Johnell, et al. 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 1033 1046 10.1007/s00198-007-0343-y 1:STN:280:DC%2BD2sznvV2hug%3D%3D 17323110 (Pubitemid 47020000)
14. MA Krieg J Cornuz C Ruffieux, et al. 2006 Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women>or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study J Bone Miner Res 21 1457 1463 10.1359/jbmr.060615 16939404 (Pubitemid 44300052)
15. B Dawson-Hughes AN Tosteson LJ Melton 3rd, et al. 2008 Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA Osteoporos Int 19 449 458 10.1007/s00198-008-0559-5 1:STN:280: DC%2BD1c7nvF2nsQ%3D%3D 18292975
16. S Fujiwara T Nakamura H Orimo, et al. 2008 Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX) Osteoporos Int 19 429 435 10.1007/s00198-007-0544-4 1:STN:280:DC%2BD1c7nvF2ntw%3D%3D 18292977
17. K Lippuner H Johansson J Kanis, et al. 2008 Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women Osteoporos Int 10.1007/s00198-008-0779-8
18. United Nations population division (2003) World population prospects: the 2002 revision and world urban prospects. Population Division of the Dept Economic and Social Affairs of the UN Secretariat
19. AC Looker HW Wahner WL Dunn, et al. 1998 Updated data on proximal femur bone mineral levels of US adults Osteoporos Int 8 468 489 10.1007/s001980050093 1:STN:280:DyaK1M%2FmslensA%3D%3D 9850356 (Pubitemid 28486716)
20. JA Kanis O Johnell A Oden, et al. 2008 FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 385 397 10.1007/s00198-007-0543-5 1:STN:280:DC%2BD1c7nvF2ntA%3D%3D 18292978
21. JA Kanis H Johansson A Oden, et al. 2004 A meta-analysis of prior corticosteroid use and fracture risk J Bone Miner Res 19 893 899 10.1359/JBMR.040134 15125788 (Pubitemid 41103445)
22. LJ Melton 3rd SJ Achenbach JB Gebhart, et al. 2007 Influence of hysterectomy on long-term fracture risk Fertil Steril 88 156 162 10.1016/j.fertnstert.2006.11.080 17270180 (Pubitemid 47001382)
23. LJ Melton 3rd S Khosla GD Malkasian, et al. 2003 Fracture risk after bilateral oophorectomy in elderly women J Bone Miner Res 18 900 905 10.1359/jbmr.2003.18.5.900 12733730 (Pubitemid 37294974)
24. LJ Melton 3rd KI Alothman S Khosla, et al. 2003 Fracture risk following bilateral orchiectomy J Urol 169 1747 1750 10.1097/01.ju.0000059281.67667.97 12686824 (Pubitemid 36443487)
25. P Vestergaard L Mosekilde 2002 Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16, 416 patients in Denmark Am J Epidemiol 156 1 10 10.1093/aje/kwf007 12076883 (Pubitemid 34680618)
26. P Vestergaard K Krogh L Rejnmark, et al. 2000 Fracture risk is increased in Crohn's disease, but not in ulcerative colitis Gut 46 176 181 10.1136/gut.46.2.176 1:STN:280:DC%2BD3c7htFWgtA%3D%3D 10644310 (Pubitemid 30305842)
27. EV Loftus Jr SJ Achenbach WJ Sandborn, et al. 2003 Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota Clin Gastroenterol Hepatol 1 465 473 10.1016/S1542-3565(03)00185-X 15017646 (Pubitemid 37413610)
28. EV Loftus Jr CS Crowson WJ Sandborn, et al. 2002 Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota Gastroenterology 123 468 475 10.1053/gast.2002.34779 12145800 (Pubitemid 34827191)
29. Y Zehnder M Luthi D Michel, et al. 2004 Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men Osteoporos Int 15 180 189 10.1007/s00198-003-1529-6 14722626 (Pubitemid 38391532)
30. P Vestergaard L Mosekilde 2003 Hyperthyroidism, bone mineral, and fracture risk-a meta-analysis Thyroid 13 585 593 10.1089/105072503322238854 12930603
31. JA Kanis 2002 Diagnosis of osteoporosis and assessment of fracture risk Lancet 359 1929 1936 10.1016/S0140-6736(02)08761-5 12057569 (Pubitemid 34615775)
32. D Marshall O Johnell H Wedel 1996 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures BMJ 312 1254 1259 1:STN:280:DyaK283isFejtw%3D%3D 8634613
33. SR Cummings D Black 1995 Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies Am J Med 98 24S 28S 10.1016/S0002-9343(05)80041-5 1:STN:280:DyaK2M3isFartA%3D%3D 7709929
34. DM Black SR Cummings HK Genant, et al. 1992 Axial and appendicular bone density predict fractures in older women J Bone Miner Res 7 633 638 10.1002/jbmr.5650070607 1:STN:280:DyaK3s%2FjsVChtw%3D%3D 1414481
35. M Schwenkglenks K Lippuner 2007 Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland Osteoporos Int 18 1481 1491 10.1007/s00198-007-0390-4 1:STN:280:DC%2BD2srosVCktg%3D%3D 17530156 (Pubitemid 47512677)
36. SR Cummings DM Black DE Thompson, et al. 1998 Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial Jama 280 2077 2082 10.1001/jama.280.24.2077 1:CAS:528:DyaK1MXjsVWruw%3D%3D 9875874 (Pubitemid 29014065)
37. DM Black PD Delmas R Eastell, et al. 2007 Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis N Engl J Med 356 1809 1822 10.1056/NEJMoa067312 1:CAS:528:DC%2BD2sXltVSktLc%3D 17476007 (Pubitemid 46698462)
38. DM Black SR Cummings DB Karpf, et al. 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535 1541 10.1016/S0140-6736(96)07088-2 1:CAS:528:DyaK2sXisFCktQ%3D%3D 8950879 (Pubitemid 26411651)
39. RM Neer CD Arnaud JR Zanchetta, et al. 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434 1441 10.1056/NEJM200105103441904 1:CAS:528:DC%2BD3MXktVSgsbw%3D 11346808 (Pubitemid 32402100)
40. B Ettinger DM Black BH Mitlak, et al. 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 282 637 645 10.1001/jama.282.7. 637 1:CAS:528:DyaK1MXlvVKqurg%3D 10517716 (Pubitemid 29384151)
41. ® Bone 44 1049 1054 10.1016/j.bone.2009.02.014 10.1016/j.bone.2009.02.014 1:CAS:528:DC%2BD1MXlslWisrw%3D 19254788
42. EV McCloskey H Johansson A Oden, et al. 2009 Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double blind, placebo-controlled randomised study Osteoporos Int 20 811 817 10.1007/s00198-008-0786-9 10.1007/s00198-008-0786-9 1:CAS:528:DC%2BD1MXjvFaqt78%3D 19002369
43. C Pongchaiyakul ND Nguyen G Jones, et al. 2005 Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study J Bone Miner Res 20 1349 1355 10.1359/JBMR.050317 16007332 (Pubitemid 41033519)
44. MC Nevitt B Ettinger DM Black, et al. 1998 The association of radiographically detected vertebral fractures with back pain and function: a prospective study Ann Intern Med 128 793 800 1:STN:280:DyaK1c3ktlSjsQ%3D%3D 9599190